1271948-76-5

Basic information

• Product Name: (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-chloropicolinamide
• Synonyms: (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-chloropicolinamide
• CAS NO: 1271948-76-5
• Molecular Weight: 378.858
• Mol File: 1271948-76-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-chloropicolinamide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-chloropicolinamide(1271948-76-5)
• EPA Substance Registry System: (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-chloropicolinamide(1271948-76-5)

Safety Data

• Hazardous Substances Data: 1271948-76-5(Hazardous Substances Data)

Upstream product

• 86873-60-1 5-chloropicolinic acid 
• 1075230-69-1 (S)-4-(5-amino-2-fluorophenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine 
• 1271949-52-0 5-chloro-pyridine-2-carboxylic acid (3-acetyl-4-fluoro-phenyl)-amide 
• 1271949-56-4 5-chloro-pyridine-2-carboxylic acid [3-((E)-3-carbamimidoylsulfanyl-1-methyl-propenyl)-4-fluoro-phenyl]-amide hydrochloride 
• 1271949-54-2 5-chloro-pyridine-2-carboxylic acid [4-fluoro-3-(1-hydroxy-1-methyl-allyl)-phenyl]-amide 
• 935999-02-3 5-chloro-pyridine-2-carboxylic acid [3-((S)-2-amino-4-methyl-5,6-dihydro-4H-[1,3]thiazin-4-yl)-4-fluoro-phenyl]-amide 
• 128073-03-0 4-chloronicotinoyl chloride 
• 67500-19-0 5'-Amino-2'-fluoroacetophenone 

Relevant articles and documents

Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2

BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer's disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments. This role of BACE2 implies that nonselective and

2 -AMINODIHYDRO [1, 3] THIAZINES AS BACE 2 INHIBITORS FOR THE TREATMENT OF DIABETES

This invention relates to the use of aminodihydrothiazines of the formula wherein R1 to R3 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof, and pharmaceutical compositions con